Pandia Health Completes US$1.5m Seed Round

Sunnyvale, CA – Pandia Health, a disruptive healthtech platform that provides integrated on-demand telemedicine and pharmacy medication delivered direct to women, is pleased to announce the successful completion of its US$1.5 million seed round. The funding was secured from a variety of experienced investors, including global growth investor Allectus Capital Limited (Allectus), Charles Hudson of Precursor Ventures, and Stanford-Start X Fund and will be utilised to scale the Pandia Health platform in the United States. This will support Pandia Health’s mission to help women obtain the education and visibility they need to take charge of their health, life, and birth control.

Pandia Health changes the pharmacy experience dramatically by bringing birth control to women wherever they have internet and a mailbox. It is the only women-founded/led, practicing reproductive health physician founded/led company in the birth control delivery space. CEO Dr. Sophia Yen's 20+ years of experience and passion in the reproductive rights and health space helps Pandia Health provide affordable, cutting-edge, and evidence-based healthcare where and when women need it.

The company plans to use the round to expand sales, marketing, and physician-led health education to its target audience of women ages 18-35. Through new marketing and patient delivery channels, the company will help women become fully informed on their birth control options and liberate them from the stress of running to the pharmacy each month.

“It’s a huge vote of confidence to have Charles Hudson of Precursor Ventures lead our round and a global investor such as Allectus Capital complete it,” said Dr. Sophia Yen, CEO and Co-Founder. "Pandia Health will greatly benefit from the experience, connections, and support from all its investors. With these funds, Pandia Health will continue to make sure no one runs out of birth control on our watch and further grow our brand to be the one women trust with their health now and always."

Dr. Yen added, “Allectus’ mandate is to invest in mission driven founders and teams serving critical customer needs that are unmet by existing markets. This represents exactly what we are trying to do, and we are excited that we can partner together to focus on getting women birth control, providing Pandia Health Peace of Mind, and educating women about #PeriodsOptional.”

Allectus’ Head of Emerging Technology, Matthew Gould, stated “Pandia Health is a strong example of the sort of smart, customer centric services that are set to increasingly disrupt the health system in the USA. Pandia Health’s great team, experienced leadership, and overall vision make for a great addition to the Allectus portfolio.”

About Pandia Health

Pandia Health is the end-to-end solution for birth control, from an online doctor’s visit to medication fulfillment and delivery. Pandia Health makes women’s lives easier by providing convenient, confidential, and cost-effective healthcare. Pandia Health is creating the Brand Women Trust with Their Health, starting with birth control and growing with women as they grow. For more information, visit,, and Pandia Health’s YouTube channel.

About Allectus Capital

Allectus Capital Limited is an investment company with a value focused technology portfolio of unlisted and listed companies. Allectus was formed to invest in, and partner with, potentially disruptive businesses in the technology sector. Allectus oversees and supports c.A$400m in technology investments, principally in the Asia Pacific and United Kingdom, for clients of ICM Limited. Allectus is an active, long-term investor, supporting both the growth of individual investments and encouraging synergies between our portfolio businesses. For more information visit and


Contact Us
  • White LinkedIn Icon
  • White Twitter Icon

34 Bermudiana Road, Hamilton, Bermuda

For a full list of ICM global office locations click here

© 2020 by Allectus Capital Limited 

We are not offering financial or other professional advice on this site. We are not liable for any damages however arising from the use of or inability to use this site, or any material contained in it, or from any action or decision taken as a result of using this site or any such material.